Lab Anim Res.  2011 Sep;27(3):259-263. 10.5625/lar.2011.27.3.259.

Esculetin inhibits N-methyl-D-aspartate neurotoxicity via glutathione preservation in primary cortical cultures

• Lee CR
• Shin EJ
• Kim HC
• Choi YS
• Shin T
• Wie MB

• KMID: 1850055
• DOI: http://doi.org/10.5625/lar.2011.27.3.259

Abstract

Recently, loss of endogenous glutathione during N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxic injury, and the resultant overproduction of reactive oxygen species (ROS) through an arachidonic acid cascade process in brain, have been implicated in neuronal damage in various neurodegenerative diseases. Glutathione depletion induced by L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of glutathione synthesis, is known to cause arachidonic acid-mediated excitotoxicity in primary mixed cortical cultures. The aim of this study was to investigate whether esculetin (6,7-dihydroxycoumarin), an inhibitor of lipoxygenase, protects against neurotoxicity induced by NMDA or BSO. We observed that neurotoxicity induced by NMDA but not kainic acid was attenuated by esculetin. At the same concentration (100 microM), esculetin attenuated the 45Ca2+ uptake elevation induced by NMDA. Free radical-mediated neuronal injury induced by H2O2 and xanthine/xanthine oxidase was concentration-dependently blocked by esculetin. Esculetin (1-30 microM) dose-dependently inhibited BSO-induced neuronal injury. In addition, arachidonate-induced neurotoxicity was completely blocked by esculetin. BSO also reduced glutathione peroxidase (GPx) activity, but did not change glutathione reductase (GR) activity 24 h after treatment. Esculetin dose-dependently increased GR activity, but did not alter GPx activity. These findings suggest that esculetin can contribute to the rescue of neuronal cells from NMDA neurotoxicity and that this protective effect occurs partly through NMDA receptor modulation and the sparing of glutathione depletion.

Keyword

Esculetin; N-methyl-D-aspartate; L-buthionine-(S,R)-sulfoximine; lipoxygenase; cortical cultures

MeSH Terms

Arachidonic Acid
Brain
Glutathione
Glutathione Reductase
Kainic Acid
Lipoxygenase
N-Methylaspartate
Neurodegenerative Diseases
Neurons
Oxidoreductases
Peroxidase
Reactive Oxygen Species
Umbelliferones
Arachidonic Acid
Glutathione
Glutathione Reductase
Kainic Acid
Lipoxygenase
N-Methylaspartate
Oxidoreductases
Peroxidase
Reactive Oxygen Species
Umbelliferones

Figure

• 

  Figure 1 Morphological evidence of neuroprotection by esculetin against N-methyl-D-aspartate (NMDA) neurotoxicity. Phase-contrast photomicrographs of sister cultures of neurons cultured with NMDA (150 µM for 5 min) alone (A) or in the presence of 100 mM esculetin (B). Neurons were stained with trypan blue. Scale bar =50 µm.

• 

  Figure 2 Esculetin attenuates NMDA-induced 45Ca2+ uptake. Sister cultures were exposed to 100 µM NMDA for 5 min in the presence of extracellular 45Ca2+: immediately following exposure, the cells were washed and lysed and intracellular 45Ca2+ measured. Bars represents mean neuronal uptake after NMDA exposure in the presence of MK-801 (10 µM) or esculetin (10 or 100 µM). *,**Significantly different from control (*P<0.05, **P<0.01).

• 

  Figure 3 Esculetin concentration-dependently inhibits BSO-induced neurotoxicity (A). Phase-contrast photomicrographs of sister cultures of neurons cultured with vehicle (B), BSO (1 mM for 24 h) alone (C) or in the presence of 30 µM esculetin (D). *Significantly different from control (P<0.05). Scale bar=50 µm.

• 

  Figure 4 Esculetin, but not cycloheximide (CHX) or vitamin E (Vit-E), significantly attenuates arachidonic acid (AA)-induced neurotoxicity in mixed cortical cultures. *Significantly different from control (P<0.05).

• 

  Figure 5 Esculetin does not change glutathione peroxidase (GP) activity (A) but increases glutathione reductase (GRx) activity (B) in BSO neurotoxicity. *,**Significantly different from normal (*P<0.05, **P<0.01). #,##Significantly different from BSO control (#P<0.05, ##P<0.01).

Reference

1. Dumuis A, Sebben M, Haynes L, Pin JP, Bockaert J. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature. 1988; 336(6194):68–70. PMID: 2847054.

2. Almeida A, Heales SJ, Bolaños JP, Medina JM. Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. 1998; 790(1-2):209–216. PMID: 9593899.

3. Taylor AL, Hewett SJ. Potassium-evoked glutamate release liberates arachidonic acid from cortical neurons. J Biol Chem. 2002; 277(46):43881–43887. PMID: 12235140.

4. Collingridge GL, Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci. 1990; 11(7):290–296. PMID: 2167544.

5. Rodriguez-Alvarez J, Blanco I, Patel AJ. Modulation of N-methyl-D-aspartate receptor mediated arachidonic acid release by endogenous nitric oxide in cultured neurons. Neurosci Lett. 1996; 218(2):95–98. PMID: 8945736.

6. Ge QF, Wie EQ, Zhang WP, Hu X, Huang XJ, Zhang L, Song Y, Ma ZQ, Chen Z, Luo JH. Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons. J Neurochem. 2006; 97(4):992–1004. PMID: 16606359.

7. Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory antioxidant activities. Curr Pharm Des. 2004; 10(30):3813–3833. PMID: 15579073.

8. Bridges RJ, Koh JY, Hatalski CG, Cotman CW. Increased excitotoxic vulnerability of cortical cultures with reduced levels of glutathione. Eur J Pharmacol. 1991; 192(1):199–200. PMID: 1674918.

9. Regan RF, Guo YP. Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione. Neuroscience. 1999; 91(2):463–470. PMID: 10366003.

10. Regan RF, Guo Y. Extracellular reduced glutathione increases neuronal vulnerability to combined chemical hypoxia and glucose deprivation. Brain Res. 1999; 817(1-2):145–150. PMID: 9889354.

11. Wie MB, Won MH, Lee KH, Shin JH, Lee JC, Suh HW, Song DK, Kim YH. Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures. Neurosci Lett. 1997; 225(2):93–96. PMID: 9147382.

12. Kim SR, Park MJ, Lee MK, Sung SH, Park EJ, Kim J, Kim SY, Oh TH, Markelonis GJ, Kim YC. Flavonoids of Inula Britannica protect cultured cortical cells from necrotic cell death induced by glutamate. Free Radic Biol Med. 2002; 32(7):596–604. PMID: 11909694.

13. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun. 1976; 71(4):952–958. PMID: 971321.

14. Eklöw L, Moldéus P, Orrenius S. Oxidation of glutathione during hydroperoxide metabolism. A study using isolated hepatocyte and the glutathione reductase inhibitor 1,3-bis(2-chloroethyl)-1-nitrosourea. Eur J Biochem. 1984; 138(3):459–463. PMID: 6692829.

15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951; 193(1):265–275. PMID: 14907713.

16. Kim HC, Jhoo WK, Bing G, Shin EJ, Wie MB, Kim WK, Ko KH. Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Res. 2000; 874(1):15–23. PMID: 10936219.

17. Taylor AL, Bonventre JV, Uliasz TF, Hewett JA, Hewett SJ. Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death. J Neurochem. 2008; 106(4):1828–1840. PMID: 18564366.